Vulcan Energy's Lionheart Countdown: Adsorbent Output Ramps Up While the Register Shifts

Vulcan Energy rose 4.1% to EUR 1.09 on broader market sentiment as Canaccord reiterated its Buy rating and VULSORB production started in Germany.

Vulcan Energy Resources closed Friday's session at EUR 1.09, a gain of 4.1 percent that owed little to anything the company itself disclosed. Instead, the stock rode a broader improvement in sentiment across commodity and equity markets, with Australian shares adding an average of 0.8 percent as US Treasury yields eased. For a company whose shares have surrendered 57 percent since the start of the year, the softer rate backdrop offered a chance for a countermove rather than any fundamental re-rating.

That distinction matters. The operational challenges facing Vulcan and its multi-year development roadmap are untouched by day-to-day swings in the share price, and market participants treated Friday's advance as a technical bounce after sustained selling pressure rather than a change of heart on the story.

Canaccord Sticks to Its Guns

The most concrete external signal came earlier in the week, when Canaccord Genuity Group reaffirmed its "Buy" rating on the stock with an unchanged price target of 308 GBX. The call places the brokerage firmly at odds with the recent downward momentum in the market, and it arrived against a backdrop of tangible operational progress on the company's production chain.

For investors, the gap between that target and the current trading level is stark — a reminder of how far sentiment has travelled from where at least one analyst house believes the value sits.

VULSORB Production as a Technical Milestone

At the heart of the operational story is Vulcan's lithium project. Roughly two weeks ago, commercial production of the company's proprietary extraction material VULSORB began in Germany. The first batches are destined for the extraction columns at the Lionheart project, and output is set to continue with a manufacturing partner over the next 18 months to two years.

Management frames the in-house manufacture of the adsorbent as a risk-reduction exercise. Producing VULSORB internally is intended to curb technological uncertainty along with dependencies in the supply chain and in project execution. Yet the milestone barely registered in the share price — since production started, the stock has shed 20.2 percent. Financing and construction of Lionheart were already addressed about a month ago, leaving the long runway to first production as the key unknown for shareholders.

Commissioning of Lionheart itself remains targeted for the second half of 2028.

Register Movements and Licensing News

Ownership structure has shifted alongside the operational developments. Francis Wedin crossed below a reportable voting-rights threshold on 24 September, according to an official regulatory filing. The Goldman Sachs Group, Inc. also featured in notifiable changes to voting rights and shareholdings.

Separately, authorities granted the Ilka licence for lithium extraction roughly three weeks ago, a step accompanied by a change of personnel on the supervisory board. The involvement of institutional players and key individuals underscores the attention the project attracts as it moves toward its planned extraction phase.

Whether Vulcan can hold to its 2028 commissioning timetable without further slippage is likely to be the decisive factor for the share price from here. Friday's reprieve buys the stock some breathing room, but it has so far come in the wake of the wider market rather than on any news of its own.